In 1998 after 12 years extensive research and armed with the rights to the patented Paterson Photodynamic Therapy lamp for worldwide distribution, Cancer Research UK (the largest charity in the UK dedicated to Cancer Research) and the University of Manchester formed Phototherapeutics Ltd (PTL) with the mission of bringing effective, inexpensive and clinically proven cancer treatments to the healthcare market.

Further research revealed that PDT delivered on a matrix of narrow beam light emitting diodes (LED) could be used for a much broader range of conditions and as these treatments area non-surgical, laser-free they could effectively and safely be administered by skincare aesthetic practitioners and as such Omnilux was created to service both the medical and skincare industries.

Omnilux plus™ transmits infra-red light (830nm) and is the most deeply penetrating wavelength, working indirectly through cell membrane absorption to stimulate complex cellular processes that result in increased collagen, elastin and growth factor production to treat the visible signs of photodamage and stimulate cellular repair mechanisms essential in the wound healing process.

• Alternating with Omnilux revive for the treatment of periorbital wrinkles and the visible signs of photodamage
• Alternating with Omnilux revive to accelerate wound healing post-surgical/post-invasive procedures
• Alone or alternating with Omnilux revive to treat or reduce the risk of PIH
• Alone as part of a muscle and sport injury rehabilitation program